Trastuzumab emtansine improves overall survival versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cance

Editor's choice for December 2015

Denosumab improves disease-free survival for postmenopausal patients with HR-positive breast cancer

Long-term outcomes after blinatumomab treatment for ALL

Chemoprevention in breast cancer and possible vaccine for prostate cancer

Response to rituximab induction is a predictive biomarker in post-transplant lymphoproliferative disorder

ASH 2015: Highlights in mantle cell lymphoma

Blinatumomab has promising effect on hard-to-treat, rare acute lymphoblastic leukaemia subtype

Rituximab plus chemotherapy improves outcomes in acute lymphoblastic leukaemia

Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia

Idelalisib combination therapy in relapsed or treatment-resistant CLL better than standard regimen

ASH 2015: Novel combination approaches for multiple myeloma